Aquatic Capital Management LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1803916 CHICAGO, IL

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,493,024

-$1,704,930 QoQ

Shares Held

12,180

-66.7% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#161

of 343 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $144,356,048 across 88 Biotechnology names. PTGX ranks #29 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	32,577	$20,313,062
2	CYTK	Cytokinetics Inc	125,090	$10,656,417
3	TVTX	Travere Therapeutics, Inc.	157,710	$8,959,505
4	ARGX	Argenx SE	7,697	$7,141,045
5	PTCT	Ptc Therapeutics, Inc.	83,470	$6,808,647
6	TGTX	Tg Therapeutics, Inc.	99,530	$5,468,178
7	ALNY	Alnylam Pharmaceuticals, Inc.	15,480	$4,659,944
8	MIRM	Mirum Pharmaceuticals, Inc.	36,670	$4,292,956

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,493,024	12,180	-66.7%	Shares	Sole	2026-08-14
2025-12-31	$3,197,954	36,615	-12.8%	Shares	Sole	2026-02-17
2025-06-30	$2,321,340	42,000	+178.0%	Shares	Sole	2025-08-14
2025-03-31	$730,574	15,107	+556.8%	Shares	Sole	2025-05-15
2024-03-31	$66,539	2,300	-73.6%	Shares	Sole	2024-05-15
2023-12-31	$199,491	8,700	+2.4%	Shares	Sole	2024-02-14
2023-09-30	$141,780	8,500	+672.7%	Shares	Sole	2023-11-14
2023-06-30	$30,382	1,100	-95.1%	Shares	Sole	2023-08-14
2022-12-31	$243,293	22,300	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.